RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Ribosomal protein mutations in Korean patients with Diamond-Blackfan anemia

      한글로보기

      https://www.riss.kr/link?id=A101634893

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Diamond-Blackfan anemia (DBA) is a congenital bone marrow failure syndrome characterized by hypoproliferative anemia, associated physical malformations and a predisposition to cancer. DBA has been associated with mutations and deletions in the large and small ribosomal protein genes, and genetic aberrations have been detected in B50–60% of patients. In this study, nine Korean DBA patients were screened for mutations in eight known DBA genes (RPS19, RPS24, RPS17, RPS10, RPS26, RPL35A, RPL5 and RPL11) using the direct sequencing method. Mutations in RPS19, RPS26 and RPS17 were detected infour, two and one patient, respectively. Among the mutations detected in RPS19, two mutations were novel (c.26T4A, c.357- 2A4G). For the mutation-negative cases, array-CGH analysis was performed to identify copy-number variations, and no deletions involving the known DBA gene regions were identified. The relative mRNA expression of RPS19 estimated using realtime quantitative PCR analysis revealed two- to fourfold reductions in RPS19 mRNA expression in three patients with RPS19 mutations, and p53 protein expression analysis by immunohistochemistry showed variable but significant nuclear staining in the DBA patients. In conclusion, heterozygous mutations in the known DBA genes RPS19, RPS26 and RPS17 were detected in seven out of nine Korean DBA patients. Among these patients, RPS19 was the most frequently mutated gene. In addition, decreased RPS19 mRNA expression and p53 overexpression were observed in the Korean DBA patients, which supports the hypothesis that haploinsufficiency and p53 hyperactivation represent a central pathway underlying the pathogenesis of DBA.
      번역하기

      Diamond-Blackfan anemia (DBA) is a congenital bone marrow failure syndrome characterized by hypoproliferative anemia, associated physical malformations and a predisposition to cancer. DBA has been associated with mutations and deletions in the large a...

      Diamond-Blackfan anemia (DBA) is a congenital bone marrow failure syndrome characterized by hypoproliferative anemia, associated physical malformations and a predisposition to cancer. DBA has been associated with mutations and deletions in the large and small ribosomal protein genes, and genetic aberrations have been detected in B50–60% of patients. In this study, nine Korean DBA patients were screened for mutations in eight known DBA genes (RPS19, RPS24, RPS17, RPS10, RPS26, RPL35A, RPL5 and RPL11) using the direct sequencing method. Mutations in RPS19, RPS26 and RPS17 were detected infour, two and one patient, respectively. Among the mutations detected in RPS19, two mutations were novel (c.26T4A, c.357- 2A4G). For the mutation-negative cases, array-CGH analysis was performed to identify copy-number variations, and no deletions involving the known DBA gene regions were identified. The relative mRNA expression of RPS19 estimated using realtime quantitative PCR analysis revealed two- to fourfold reductions in RPS19 mRNA expression in three patients with RPS19 mutations, and p53 protein expression analysis by immunohistochemistry showed variable but significant nuclear staining in the DBA patients. In conclusion, heterozygous mutations in the known DBA genes RPS19, RPS26 and RPS17 were detected in seven out of nine Korean DBA patients. Among these patients, RPS19 was the most frequently mutated gene. In addition, decreased RPS19 mRNA expression and p53 overexpression were observed in the Korean DBA patients, which supports the hypothesis that haploinsufficiency and p53 hyperactivation represent a central pathway underlying the pathogenesis of DBA.

      더보기

      다국어 초록 (Multilingual Abstract)

      Diamond-Blackfan anemia (DBA) is a congenital bone marrow failure syndrome characterized by hypoproliferative anemia, associated physical malformations and a predisposition to cancer. DBA has been associated with mutations and deletions in the large and small ribosomal protein genes, and genetic aberrations have been detected in B50–60% of patients. In this study, nine Korean DBA patients were screened for mutations in eight known DBA genes (RPS19, RPS24, RPS17, RPS10, RPS26, RPL35A, RPL5 and RPL11) using the direct sequencing method. Mutations in RPS19, RPS26 and RPS17 were detected infour, two and one patient, respectively. Among the mutations detected in RPS19, two mutations were novel (c.26T4A, c.357- 2A4G). For the mutation-negative cases, array-CGH analysis was performed to identify copy-number variations, and no deletions involving the known DBA gene regions were identified. The relative mRNA expression of RPS19 estimated using realtime quantitative PCR analysis revealed two- to fourfold reductions in RPS19 mRNA expression in three patients with RPS19 mutations, and p53 protein expression analysis by immunohistochemistry showed variable but significant nuclear staining in the DBA patients. In conclusion, heterozygous mutations in the known DBA genes RPS19, RPS26 and RPS17 were detected in seven out of nine Korean DBA patients. Among these patients, RPS19 was the most frequently mutated gene. In addition,decreased RPS19 mRNA expression and p53 overexpression were observed in the Korean DBA patients, which supports the hypothesis that haploinsufficiency and p53 hyperactivation represent a central pathway underlying the pathogenesis of DBA.
      번역하기

      Diamond-Blackfan anemia (DBA) is a congenital bone marrow failure syndrome characterized by hypoproliferative anemia, associated physical malformations and a predisposition to cancer. DBA has been associated with mutations and deletions in the large a...

      Diamond-Blackfan anemia (DBA) is a congenital bone marrow failure syndrome characterized by hypoproliferative anemia, associated physical malformations and a predisposition to cancer. DBA has been associated with mutations and deletions in the large and small ribosomal protein genes, and genetic aberrations have been detected in B50–60% of patients. In this study, nine Korean DBA patients were screened for mutations in eight known DBA genes (RPS19, RPS24, RPS17, RPS10, RPS26, RPL35A, RPL5 and RPL11) using the direct sequencing method. Mutations in RPS19, RPS26 and RPS17 were detected infour, two and one patient, respectively. Among the mutations detected in RPS19, two mutations were novel (c.26T4A, c.357- 2A4G). For the mutation-negative cases, array-CGH analysis was performed to identify copy-number variations, and no deletions involving the known DBA gene regions were identified. The relative mRNA expression of RPS19 estimated using realtime quantitative PCR analysis revealed two- to fourfold reductions in RPS19 mRNA expression in three patients with RPS19 mutations, and p53 protein expression analysis by immunohistochemistry showed variable but significant nuclear staining in the DBA patients. In conclusion, heterozygous mutations in the known DBA genes RPS19, RPS26 and RPS17 were detected in seven out of nine Korean DBA patients. Among these patients, RPS19 was the most frequently mutated gene. In addition,decreased RPS19 mRNA expression and p53 overexpression were observed in the Korean DBA patients, which supports the hypothesis that haploinsufficiency and p53 hyperactivation represent a central pathway underlying the pathogenesis of DBA.

      더보기

      참고문헌 (Reference)

      1 Matsson H, "Truncating ribosomal protein S19 mutations and variable clinical expression in Diamond-Blackfan anemia" 105 : 496-500, 1999

      2 Boria I, "The ribosomal basis of Diamond-Blackfan Anemia : mutation and database update" 31 : 1269-1279, 2010

      3 lachos A, "The Diamond Blackfan Anemia Registry : tool for investigating the epidemiology and biology of Diamond-Blackfan anemia" 23 : 377-382, 2001

      4 Proust A, "Ten novel Diamond-Blackfan anemia mutations and three polymorphisms within the rps19 gene" 4 : 132-136, 2003

      5 Zhang Y, "Signaling to p53 : ribosomal proteins find their way" 16 : 369-377, 2009

      6 Doherty L, "Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia" 86 : 222-228, 2010

      7 Farrar JE, "Ribosomal protein gene deletions in Diamond-Blackfan anemia" 118 : 6943-6951, 2011

      8 Danilova N, "Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family" 112 : 5228-5237, 2008

      9 Cmejla R, "Ribosomal protein S17 gene(RPS17)is mutated in Diamond-Blackfan anemia" 28 : 1178-1182, 2007

      10 Campagnoli MF, "RPS19 mutations in patients with Diamond-Blackfan anemia" 29 : 911-920, 2008

      1 Matsson H, "Truncating ribosomal protein S19 mutations and variable clinical expression in Diamond-Blackfan anemia" 105 : 496-500, 1999

      2 Boria I, "The ribosomal basis of Diamond-Blackfan Anemia : mutation and database update" 31 : 1269-1279, 2010

      3 lachos A, "The Diamond Blackfan Anemia Registry : tool for investigating the epidemiology and biology of Diamond-Blackfan anemia" 23 : 377-382, 2001

      4 Proust A, "Ten novel Diamond-Blackfan anemia mutations and three polymorphisms within the rps19 gene" 4 : 132-136, 2003

      5 Zhang Y, "Signaling to p53 : ribosomal proteins find their way" 16 : 369-377, 2009

      6 Doherty L, "Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia" 86 : 222-228, 2010

      7 Farrar JE, "Ribosomal protein gene deletions in Diamond-Blackfan anemia" 118 : 6943-6951, 2011

      8 Danilova N, "Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family" 112 : 5228-5237, 2008

      9 Cmejla R, "Ribosomal protein S17 gene(RPS17)is mutated in Diamond-Blackfan anemia" 28 : 1178-1182, 2007

      10 Campagnoli MF, "RPS19 mutations in patients with Diamond-Blackfan anemia" 29 : 911-920, 2008

      11 Gazda HT, "RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations" 127 : 105-113, 2004

      12 Bessler M, "Nathan and Oski’s hematology of infancy and childhood" Saunders 351-360, 2008

      13 Konno Y, "Mutations in the ribosomal protein genes in Japanese patients with Diamond-Blackfan anemia" 95 : 1293-1299, 2010

      14 den Dunnen JT, "Mutation nomenclature extensions and suggestions to describe complex mutations : a discussion" 15 : 7-12, 2000

      15 Horos R, "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia" 159 : 514-527, 2012

      16 Gregory LA, "Molecular basis of Diamond-Blackfan anemia : structure and function analysis of RPS19" 35 : 5913-5921, 2007

      17 Campagnoli MF, "Molecular basis of Diamond-Blackfan anemia : new findings from the Italian registry and a review of the literature" 89 : 480-489, 2004

      18 Willig TN, "Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Societe d’Hematologie et d’Immunologie Pediatrique (SHIP), Gesellshaft fur Padiatrische Onkologie und Hamatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI)" 46 : 553-561, 1999

      19 Dutt S, "Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells" 117 : 2567-2576, 2011

      20 Hamaguchi I, "Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia" 15 : 2724-3271, 2002

      21 Gazda HT, "Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-ribosomal RNA processing defect in diamond-blackfan anemia" 33 : 1037-1044, 2012

      22 Kuramitsu M, "Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia" 119 : 2376-2384, 2012

      23 채효진, "Diamond-Blackfan Anemia Confirmed by RPS19 Gene Mutation Analysis: A Case Study and Literature Review of Korean Patients" 대한진단검사의학회 30 (30): 249-254, 2010

      24 Orfali KA, "Diamond Blackfan anaemia in the UK : clinical and genetic heterogeneity" 125 : 243-252, 2004

      25 Vlachos A, "Diagnosing and treating Diamond Blackfan anaemia : results of an international clinical consensus conference" 142 : 859-876, 2008

      26 Song MJ, "A novel initiation codon mutation in the ribosomal protein S17 gene(RPS17)in a patient with Diamond-Blackfan anemia" 54 : 629-631, 2010

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2009-09-21 학회명변경 한글명 : 대한생화학ㆍ분자생물학회 -> 생화학분자생물학회
      영문명 : Korean Society Of Medical Biochemistry And Molecular Biology -> Korean Society Of Biochemistry And Molecular Biology
      KCI등재
      2008-01-01 평가 SCI 등재 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 3.74 0.23 2.56
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.82 1.45 0.555 0.01
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼